IRIS Accounts Production v24.3.0.553 03217953 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh032179532023-03-31032179532024-03-31032179532023-04-012024-03-31032179532022-03-31032179532022-04-012023-03-31032179532023-03-3103217953ns15:EnglandWales2023-04-012024-03-3103217953ns14:PoundSterling2023-04-012024-03-3103217953ns10:Director12023-04-012024-03-3103217953ns10:Director22023-04-012024-03-3103217953ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3103217953ns10:SmallEntities2023-04-012024-03-3103217953ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3103217953ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3103217953ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3103217953ns10:FullAccounts2023-04-012024-03-3103217953ns10:OrdinaryShareClass12023-04-012024-03-3103217953ns10:RegisteredOffice2023-04-012024-03-3103217953ns5:CurrentFinancialInstruments2024-03-3103217953ns5:CurrentFinancialInstruments2023-03-3103217953ns5:ShareCapital2024-03-3103217953ns5:ShareCapital2023-03-3103217953ns5:RetainedEarningsAccumulatedLosses2024-03-3103217953ns5:RetainedEarningsAccumulatedLosses2023-03-3103217953ns5:PlantMachinery2023-04-012024-03-3103217953ns5:PlantMachinery2023-03-3103217953ns5:PlantMachinery2024-03-3103217953ns5:PlantMachinery2023-03-3103217953ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3103217953ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3103217953ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 03217953 (England and Wales)















LONG CLAWSON MEDICAL SERVICES LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024






LONG CLAWSON MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 03217953)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


LONG CLAWSON MEDICAL SERVICES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Dr P S Rathbone
Dr S C Wooding





REGISTERED OFFICE: The Sands
Long Clawson
Melton Mowbray
Leicestershire
LE14 4PA





REGISTERED NUMBER: 03217953 (England and Wales)





ACCOUNTANTS: Duncan & Toplis Limited
18 Northgate
Sleaford
Lincolnshire
NG34 7BJ

LONG CLAWSON MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 03217953)

STATEMENT OF FINANCIAL POSITION
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 6,244 7,896

CURRENT ASSETS
Debtors 5 117,355 184,679
Cash at bank 231,625 138,241
348,980 322,920
CREDITORS
Amounts falling due within one year 6 75,422 85,566
NET CURRENT ASSETS 273,558 237,354
TOTAL ASSETS LESS CURRENT LIABILITIES 279,802 245,250

PROVISIONS FOR LIABILITIES 1,186 1,500
NET ASSETS 278,616 243,750

CAPITAL AND RESERVES
Called up share capital 7 900 900
Retained earnings 277,716 242,850
SHAREHOLDERS' FUNDS 278,616 243,750

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on 14 November 2024 and were signed on its behalf by:




Dr S C Wooding - Director



Dr P S Rathbone - Director


LONG CLAWSON MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 03217953)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

Long Clawson Medical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance and 10% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 (2023 - 13 ) .

LONG CLAWSON MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 03217953)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2023
and 31 March 2024 49,285
DEPRECIATION
At 1 April 2023 41,389
Charge for year 1,652
At 31 March 2024 43,041
NET BOOK VALUE
At 31 March 2024 6,244
At 31 March 2023 7,896

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 67,529 63,402
Other debtors 49,826 121,277
117,355 184,679

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 51,744 53,192
Taxation and social security 10,960 15,774
Other creditors 12,718 16,600
75,422 85,566

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
900 Ordinary £1 900 900

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

At the year end date, the company owed Dr S C Wooding £5,000 (2023 - £4,000) and Dr P S Rathbone £5,000 (2023 - £4,000).

The director's loan accounts are unsecured, repayable on demand and interest free.